309 related articles for article (PubMed ID: 11093060)
21. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
[TBL] [Abstract][Full Text] [Related]
22. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
23. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
24. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
Matias-Guiu X; Bussaglia E; Catasus L; Lagarda H; Gras E; Machin P; Prat J
Clin Cancer Res; 2000 Apr; 6(4):1598-600. PubMed ID: 10778994
[No Abstract] [Full Text] [Related]
25. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.
Viganó P; Somigliana E; Chiodo I; Abbiati A; Vercellini P
Hum Reprod Update; 2006; 12(1):77-89. PubMed ID: 16172112
[TBL] [Abstract][Full Text] [Related]
27. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
29. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.
Simpkins SB; Peiffer-Schneider S; Mutch DG; Gersell D; Goodfellow PJ
Gynecol Oncol; 1998 Dec; 71(3):391-5. PubMed ID: 9887237
[TBL] [Abstract][Full Text] [Related]
30. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
31. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations.
Kolasa IK; Rembiszewska A; Janiec-Jankowska A; Dansonka-Mieszkowska A; Lewandowska AM; Konopka B; Kupryjańczyk J
Gynecol Oncol; 2006 Nov; 103(2):692-7. PubMed ID: 16793127
[TBL] [Abstract][Full Text] [Related]
32. [Ovarian cancers complicated by endometriosis].
Obata K; Koike H; Shiina M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():615-22. PubMed ID: 15535319
[No Abstract] [Full Text] [Related]
33. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.
Ricci R; Komminoth P; Bannwart F; Torhorst J; Wight E; Heitz PU; Caduff RF
Diagn Mol Pathol; 2003 Jun; 12(2):71-8. PubMed ID: 12766611
[TBL] [Abstract][Full Text] [Related]
34. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
35. Endometriosis and the neoplastic process.
Varma R; Rollason T; Gupta JK; Maher ER
Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
39. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
[TBL] [Abstract][Full Text] [Related]
40. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
